Axolotl Biologix, an innovative biotechnology leader in regenerative medicine, is proud to announce its Chief Science Officer, Robert Kellar, Ph.D., has been recognized as one of Arizona’s top healthcare leaders.
Phoenix, AZ (May 22, 2019) - Axolotl Biologix, an innovative biotechnology leader in regenerative medicine, is proud to announce its Chief Science Officer, Robert Kellar, Ph.D., has been recognized as one of Arizona’s top healthcare leaders. Arizona Business Magazine’s editorial board selected Kellar as one of 2019’s Healthcare Researchers of the Year.
The business magazine called Kellar a highly respected biotechnology innovator, listing his regenerative medicine technologies, Axolotl Shot and Axolotl DualGraft, as evidence of his valued contributions to the field. These technologies enable the body’s tissues and cells to repair and regenerate, giving patients new options to improve outcomes without the costs and discomforts of surgery.
“I am honored to be recognized along with this highly esteemed group of researchers who are dedicated to shaping the future of healthcare in Arizona,” said Kellar. “I have made it my life’s work to research and develop innovative therapeutic options that disrupt traditional treatments and I am grateful to Axolotl Biologix for giving me an incredible team that has accomplished so much, so quickly.”
Kellar has spent nearly 20-years developing, manufacturing, and commercializing medical devices and technologies both as a researcher and professor. He’s currently at Northern University Arizona serving as an Associate Professor in the Center for Bioengineering Innovation, Co-Director of the Bioengineering Ph.D. Program, Co-Director for the Imaging & Histology Core Facility (IHCF), and an adjunct faculty member in Mechanical Engineering.
Axolotl Biologix is a national leader in regenerative medicine with liquid and membrane allograft products to help promote repair and regeneration of damaged tissues. Kellar’s team also created Axolotl Ambient™, the first commercially available room temperature regenerative fluid product that is now available through federal agencies such as the Veterans Administration and Indian Health Services.
Arizona Business Magazine named Kellar among the five Healthcare Researchers of the Year in its May issue honoring 2019 Healthcare Leaders of the Year. The other honorees are Marc Jacofsky, Ph.D., Chief Science Officer for The CORE Institute, Akinlolu O. Ojo, M.D., Associate Vice President for Clinical Research and Global Health Initiatives at the University of Arizona Health Sciences, Sunil Sharma, M.D., Deputy Director of Clinical Sciences for Translational Genomics Research Institute and Kris Vijay, M.D., Medical Director for the Institute of Congestive Heart Failure at Abrazo Arizona Heart Hospital.
About Axolotl Biologix:
Axolotl Biologix, Inc. is an innovative biotechnology leader in regenerative medicine through research, technology and clinical application. Axolotl Biologix is expanding the human body’s ability to regenerate by developing and manufacturing regenerative human cell and tissue medical technologies that are disrupting traditional, more invasive, painful and expensive treatment protocols. For more information, visit www.axobio.com
Media Contact:
Josh Weiss
10 to 1 Public Relations
480-789-0743
Laura Slawny
10 to 1 Public Relations
480-868-9423
